Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Why is RXRX moving today? Recursion Pharmaceuticals (RXRX) fell 4.23% after disappointing Q2 earnings and revenue miss, contrasting with a 1.27% gain in the healthcare sector. Recursion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results